Polsinelli Podcasts - FDA Denies Amgen Citizen Petition in Biosimilar Dispute
Over the past few weeks, numerous biologics and biosimilar companies released their quarterly earnings for Q1 2018 and held related earnings calls. Below are some highlights...more
Here are our picks for the top-5 biggest deals in the world of biosimilars in 2017...more
Last year, Sandoz filed a declaratory judgment action against Amgen and Roche related to its etanercept biosimilar drug product, which it developed to compete with Amgen's Enbrel® TNF inhibitor. Specifically, Enbrel® is a...more